What is the interpretation of fetal heart tracings (FHTs) showing Category II with repetitive late decelerations, moderate variability, and accelerations, indicating an overall reactive and reassuring pattern?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Category II fetal heart tracings with prolonged deceleration, but overall reactive with moderate variability, do not necessitate immediate delivery, and management should focus on close monitoring and addressing potential causes of the deceleration. The presence of moderate variability and reactivity in the tracing are reassuring signs that suggest adequate fetal oxygenation despite the deceleration 1. The management approach should include:

  • Continuous electronic fetal monitoring to closely observe any changes in the fetal heart rate pattern
  • Maternal position changes, particularly left lateral positioning, to improve uteroplacental perfusion
  • Oxygen administration at 10L/min via face mask if needed, to ensure adequate maternal oxygenation
  • Discontinuation of oxytocin if being administered, as it may be contributing to the deceleration
  • Consideration of an intravenous fluid bolus (500-1000mL of lactated Ringer's solution) to address potential maternal hypotension The prolonged deceleration may be caused by cord compression, placental insufficiency, or maternal hypotension, so addressing these potential causes is important 1. If the tracing doesn't improve within 30 minutes or deteriorates to Category III, preparation for expedited delivery may be necessary. Documentation of interventions and the fetal response is essential for ongoing management decisions. The NICHD guidelines support a three-category system for interpreting fetal heart rate tracings, and Category II tracings, such as this one, require increased frequency of interventions and close monitoring 1.

From the Research

Fetal Heart Rate Tracings

  • Fetal heart rate tracings are used to assess fetal well-being during labor, with different categories indicating varying levels of concern 2
  • Category II tracings, such as the one described, indicate a non-reassuring fetal status, but with some compensatory mechanisms still present 2
  • The presence of moderate variability and accelerations in the tracing suggests that the fetus is still able to mount some compensatory responses to stress 2

Decelerations

  • Decelerations in fetal heart rate tracings can be a sign of fetal distress, but can also be caused by other factors such as umbilical cord compression 3
  • The type and severity of decelerations can provide information about the underlying cause of the fetal distress 3
  • In this case, the presence of prolonged decelerations is concerning, but the overall reactive and reassuring pattern of the tracing suggests that the fetus is still able to compensate for the stress 2

Clinical Context

  • The clinical context, including the progress of labor, fetal size and reserves, and presence of meconium staining or intrauterine inflammation, is important in interpreting fetal heart rate tracings 2
  • The use of amnioinfusion or other interventions may be considered in cases where fetal distress is suspected, but the decision to intervene should be based on a thorough evaluation of the clinical context and the fetal heart rate tracing 3, 4

Management

  • The management of fetal heart rate tracings should be individualized, taking into account the specific characteristics of the tracing and the clinical context 2
  • The use of terbutaline or other medications may be considered in cases where fetal distress is suspected, but the effects of these medications on the fetal heart rate should be carefully monitored 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pathophysiological interpretation of fetal heart rate tracings in clinical practice.

American journal of obstetrics and gynecology, 2023

Research

Amnioinfusion.

European journal of obstetrics, gynecology, and reproductive biology, 1996

Research

Terbutaline: effects on the fetal heart at term.

Journal of perinatal medicine, 2011

Related Questions

What is the next step for diagnosis in a patient at 18 weeks gestation with decreased fetal movement and no fetal heartbeat, despite previous normal findings?
What are the four types of fetal heart rate (FHR) variability and their causes?
When is daily fetal monitoring recommended in high-risk pregnancies?
What measures should be taken during the first prenatal consultation?
What is the management plan for a 34-year-old woman, gravida 5 para 4, at 39 weeks gestation with a history of uncomplicated pregnancy, prepregnancy body mass index (BMI) of 33 kg/m2, and a weight gain of 18 kg, who presents with contractions and spontaneous rupture of membranes, and develops recurrent variable decelerations after receiving neuraxial anesthesia, which resolve with amnioinfusion?
What is the half-life of fentanyl (Emergency Department) for pain control?
Is monitoring urine acetoacetate levels more accurate than serum beta-hydroxybutyrate levels for detecting diabetic ketoacidosis (DKA) in adolescent patients with Type 1 Diabetes Mellitus (T1DM)?
What are the causes and treatment options for patellar dislocation (kneecap dislocation)?
What are the conservative treatment options for stenosing tenosynovitis (trigger finger) that are effective over time?
What is the likely diagnosis for a 12-year-old girl with recurrent episodes of asymmetrical nonpitting edema and a family history of similar episodes?
What can be done to improve stage 1 hypertension in a 72-year-old female patient on Losartan (losartan) 25mg daily monotherapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.